• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Verastem, Inc. - Common Stock (NQ:VSTM)

    10.36 +0.29 (+2.93%)
    Streaming Delayed Price Updated: 10:07 AM EST, Dec 4, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 155,387
    Open 9.990
    Bid (Size) 10.32 (100)
    Ask (Size) 10.39 (200)
    Prev. Close 10.06
    Today's Range 9.970 - 10.40
    52wk Range 3.455 - 11.24
    Shares Outstanding 44,784,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Verastem Oncology to Present at the 8th Annual Evercore Healthcare Conference
    From Verastem Oncology
    Via Business Wire
    News headline image
    Red Cat Posts Downbeat Q3 Results, Joins StubHub, WhiteFiber And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
     
    Via Benzinga

    Performance

    YTD
    +59.6%
    +59.6%
    1 Month
    +4.6%
    +4.6%
    3 Month
    +9.0%
    +9.0%
    6 Month
    +67.8%
    +67.8%
    1 Year
    +92.1%
    +92.1%

    More News

    Read More
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants
    From Verastem Oncology
    Via Business Wire
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    Verastem Stock Ignites Retail Buzz After Early Cancer Drug Data Show Tumor Reduction, Mild Side Effects ↗
    Via Stocktwits
    News headline image
    Verastem Oncology Announces Proposed Public Offering of Common Stock
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology to Present at Upcoming Investor Conferences
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Inc (NASDAQ:VSTM) Reports Q3 2025 Revenue Beat Amid Widened Loss ↗
    Via Chartmill
    News headline image
    Verastem Oncology Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
    From Verastem Oncology
    Via Business Wire
    News headline image
    Earnings Scheduled For August 7, 2025 ↗
    Via Benzinga
    News headline image
    Verastem Oncology Announces Encouraging Preliminary Data from Ongoing Phase 1/2a Dose Escalation Trial of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in Patients with KRAS G12D Mutant Solid Tumors
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology to Report Third Quarter 2025 Financial Results on November 4, 2025
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology Announces Updated Data from Partner GenFleet Therapeutics’ Phase 1/2 Monotherapy Study in China of GFH375 (VS-7375) in Advanced KRAS G12D Mutant Pancreatic Ductal Adenocarcinoma
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology to Present at Upcoming Investor Conferences
    From Verastem Oncology
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗
    Via Chartmill
    News headline image
    Verastem Oncology Announces Late-Breaking Abstract from Partner GenFleet Therapeutics’ Study in China of GFH375 (VS-7375) in Advanced Non-Small Cell Lung Cancer at IASLC 2025 World Conference on Lung Cancer
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology Granted Fast Track Designation for VS-7375 for the Treatment of KRAS G12D-mutated Locally Advanced or Metastatic Pancreatic Cancer
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology Announces Publication of the Primary Results from the Phase 2 RAMP 201 Trial of Avutometinib in Combination with Defactinib in Patients with Recurrent Low-Grade Serous Ovarian Cancer in the Journal of Clinical Oncology
    From Verastem Oncology
    Via Business Wire
    News headline image
    Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies
    Via FinancialNewsMedia
    News headline image
    Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies
    From FN Media Group LLC
    Via GlobeNewswire

    Frequently Asked Questions

    Is Verastem, Inc. - Common Stock publicly traded?
    Yes, Verastem, Inc. - Common Stock is publicly traded.
    What exchange does Verastem, Inc. - Common Stock trade on?
    Verastem, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Verastem, Inc. - Common Stock?
    The ticker symbol for Verastem, Inc. - Common Stock is VSTM on the Nasdaq Stock Market
    What is the current price of Verastem, Inc. - Common Stock?
    The current price of Verastem, Inc. - Common Stock is 10.36
    When was Verastem, Inc. - Common Stock last traded?
    The last trade of Verastem, Inc. - Common Stock was at 12/04/25 10:07 AM ET
    What is the market capitalization of Verastem, Inc. - Common Stock?
    The market capitalization of Verastem, Inc. - Common Stock is 463.74M
    How many shares of Verastem, Inc. - Common Stock are outstanding?
    Verastem, Inc. - Common Stock has 464M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.